OPEN PUBLIC MEETING – Multiple MolDX Policies: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis and MolDX: Genetic Testing for Heritable Thoracic Aortic Disease

October 10, 2024|1:00 p.m. to 3:00 p.m. CT
Teleconference only

AGENDA

  1. Welcome and Introductions
  2. Public Comments on Proposed LCD
    • MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
    • MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
  3. Closing Remarks
Last Updated Aug 30 , 2024